Your browser doesn't support javascript.
loading
A prospective, multicenter phase II study of continuous infusion of FLAG for patients older than 60 yr with resistant acute myeloid leukemia: a comparison with intensive younger patients' trial.
Kim, Hawk; Lee, Je-Hwan; Joo, Young-Don; Bae, Sung Hwa; Lee, Jung-Hee; Kim, Dae-Young; Lee, Won-Sik; Ryoo, Hun-Mo; Jo, Jae-Cheol; Choi, Yunsuk; Lee, Kyoo-Hyung.
Afiliación
  • Kim H; Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Korea.
  • Joo YD; Department of Hematology/Oncology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Bae SH; Department of Hematology-Oncology, Daegu Catholic University Medical Center, Catholic University of Daegu School of Medicine, Daegu, Korea.
  • Lee JH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Korea.
  • Kim DY; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Korea.
  • Lee WS; Department of Hematology/Oncology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Ryoo HM; Department of Hematology-Oncology, Daegu Catholic University Medical Center, Catholic University of Daegu School of Medicine, Daegu, Korea.
  • Jo JC; Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Choi Y; Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Lee KH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Korea.
Eur J Haematol ; 96(2): 188-97, 2016 Feb.
Article en En | MEDLINE | ID: mdl-25891993

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vidarabina / Idarrubicina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Citarabina Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vidarabina / Idarrubicina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Citarabina Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2016 Tipo del documento: Article